New Vitalbacteria Website We’re thrilled to announce the launch of Vitalbacteria, your trusted source for high-quality MBLA (Molecular Bacterial Load Assay) kits. The new website is now live, offering researchers, clinicians, and laboratories an efficient way to...
SimpliciTB / PanACEA Annual Meeting 2025 SimpliciTB / PanACEA Annual Meeting 2025 Convenes in Cape Town Cape Town, South Africa – 3rd to 5th June 2025 A successful and inspiring Annual Meeting of the SimpliciTB and PanACEA II consortium was held in Cape Town earlier...
The Lancet Infectious Diseases Publication We are delighted to announce that our paper “Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for Drug-sensitive and Drug-resistant Pulmonary Tuberculosis treatment – a phase 2c, open-label, multicentre, partially...
Strengthening Clinical trial Capacity Development in Tanzania, Malawi, Gabon & Mozambique OptiRiMoxTB – An international pragmatic trial with Optimised dose of Rifampicin and Moxifloxacin for the treatment of drug susceptible pulmonary tuberculosis (TB) The...
Some of these cookies are essential, while others help us to improve your experience.
For more information visit our cookie notice.
Necessary cookies
Necessary cookies enable core functionality. The website cannot function properly without these cookies which can only be disabled by changing your browser preferences.
These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site.
Warning: some cookies require your attention
Consent for the following cookies could not be automatically revoked. Please follow the link(s) below to opt out manually.
These cookies are set through our site by third-party provided features. They may be used by those companies to build a profile of your interests and show you relevant ads on other sites.
Warning: some cookies require your attention
Consent for the following cookies could not be automatically revoked. Please follow the link(s) below to opt out manually.
